New hope for kids with tough leukemia: experimental drug enters human testing

NCT ID NCT07306832

Recruiting now Disease control Sponsor: AbbVie Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 8 times

Summary

This early-stage study is testing an experimental drug called pivekimab sunirine in about 18 children whose acute myeloid leukemia (AML) has come back or not responded to standard treatments. The main goals are to check the drug's safety and how it moves through the body. Participants will receive the drug by IV, and researchers will monitor side effects and any signs that the leukemia is responding.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute myeloid leukemia Recurrence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE MYELOID LEUKEMIA

Contacts and locations

Locations

Children's Medical Center Dallas /ID# 275930
RECRUITING

Dallas, Texas, 75235, United States
Chu Bordeaux - Hopital Pellegrin /ID# 277645
RECRUITING

Bordeaux, New Aquitaine, 33076, France
Hopital Armand Trousseau /ID# 276231
RECRUITING

Paris, 75571, France
Lucile Packard Children's Hospital /ID# 276015
RECRUITING

Palo Alto, California, 94304, United States
National Taiwan University Hospital /ID# 276635
RECRUITING

Taipei, 100, Taiwan
New York Medical College /ID# 275597
RECRUITING

Valhalla, New York, 10595, United States
Ospedale Pediatrico Bambino Gesu /ID# 275692
RECRUITING

Rome, Roma, 00165, Italy
Perth Children'S Hospital /ID# 275673
RECRUITING

Perth, Western Australia, 6009, Australia
Samsung Medical Center /ID# 276979
RECRUITING

Seoul, Seoul Teugbyeolsi, 06351, South Korea
Seoul National University Hospital /ID# 276978
RECRUITING

Seoul, Seoul Teugbyeolsi, 03080, South Korea
Tristar Centennial Medical Center /ID# 275831
RECRUITING

Nashville, Tennessee, 37203, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.